TrialInvestigational new drugs2013

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.

Patrick A Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.